iBio (FRA:0JV0) General and Admin. Expense: €9.07 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0JV0 iBio Inc FRA:0JV0
32 GF Score
Price €1.08
! 3 Warning Signs
View Full Analysis

What is iBio General and Admin. Expense?

iBio FRA:0JV0 +4.14% 32 General and Admin. Expense is €9.07 Mil as of Jun. 2026. GuruFocus rates FRA:0JV0 with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. iBio's General and Admin. Expense for the three months ended in Jun. 2026 was €-1.89 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 was €9.07 Mil.

iBio General and Admin. Expense Related Terms

iBio General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for iBio's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iBio General and Admin. Expense Chart

iBio Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.58 17.55 10.85 9.27 9.20

iBio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 2.13 4.41 4.42 -1.89
FRA:0JV0
32GF Score
iBio Inc FRA:0JV0
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iBio General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of €9.07 Mil mean?
iBio (FRA:0JV0) has a General and Admin. Expense of €9.07 Mil as of Jun. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on iBio and its competitors.
Is iBio's General and Admin. Expense too high?
iBio's current General and Admin. Expense is €9.07 Mil. Overall, iBio has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does iBio's General and Admin. Expense compare to BSEM and CSBR?
iBio's General and Admin. Expense of €9.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on iBio and its competitors. iBio's current General and Admin. Expense is €9.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iBio stock overvalued right now?
iBio (FRA:0JV0) has a current General and Admin. Expense of €9.07 Mil. The current General and Admin. Expense is €9.07 Mil. iBio's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For iBio (FRA:0JV0), the current General and Admin. Expense is €9.07 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iBio Business Description

Other Exchanges IBIO:USA
Address 11750 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
32GF Score

Get the complete analysis for FRA:0JV0

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.08
Price